z-logo
Premium
Enhance Solar‐Light‐Driven Photocatalytic Degradation of Norfloxacin Aqueous Solution by RGO‐Based Cd x Zn 1‐x S Alloy Composite with Band‐Gap Tuneability
Author(s) -
Kar Sayani,
Ibrahim Sk,
Pal Tanusri,
Ghosh Surajit
Publication year - 2020
Publication title -
chemistryselect
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 34
ISSN - 2365-6549
DOI - 10.1002/slct.201903755
Subject(s) - photocatalysis , nanorod , materials science , norfloxacin , alloy , aqueous solution , chemical engineering , composite number , degradation (telecommunications) , nanotechnology , chemistry , metallurgy , antibiotics , composite material , catalysis , organic chemistry , telecommunications , biochemistry , ciprofloxacin , computer science , engineering
Abstract The development of efficient photocatalyst for effective removal of antibiotics from aqueous solution is of great significance to protect the human and aquatic animals from antibiotic‐resistant. Herein, we report the solar light‐responsive photocatalytic activity of Cd x Zn 1‐x S alloy semiconducting nanorods towards the degradation of norfloxacin, which is a widely used for treatment at reverse transcriptase inhibitor Urinary tract infection / respiratory tract infections and hospital‐acquired infections. The Cd 0.8 Zn 0.2 S alloy nanorod photocatalyst shows the highest photocatalytic activity with 71% degradation efficiency, which increases significantly with high degradation efficiency of 90%, after the formation of composite with RGO (reduced graphene oxide). In the composite, the RGO mats provide a duel role; it acts as a nucleation center as well as solid support for Cd x Zn 1‐x S nanorods. The accountable reactive species for the degradation of norfloxacin are also explored expansively which exhibits that the hole has the most dominating role toward the degradation of norfloxacin. This work paves a simple eco‐friendly green pathway for the efficient removal of antibiotics aquatic pollutants under solar illumination.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here